by Benzinga Insights | Oct 23, 2026 | General
Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 20 years by 12.04% on an annualized basis producing an average annual return of 20.96%. Currently, Ligand Pharmaceuticals has a market capitalization of $6.28 billion. Buying $1000 In LGND:...
by Benzinga Insights | Oct 23, 2026 | General
Kinsale Cap Gr (NYSE:KNSL) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please...
by Benzinga Insights | Oct 23, 2026 | General
Customers Bancorp (NYSE:CUBI) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog,...
by Dylan Berman | Oct 23, 2026 | General
Microsoft Corporation (NASDAQ:MSFT) shares are in the spotlight, with earnings on deck, Azure growth and capital spending in focus, recent analyst activity, a technical setup showing a short-term cooldown and Edge Rankings all drawing attention. Microsoft shares are...
by Benzinga Insights | Oct 23, 2026 | General
Amerant Bancorp (NYSE:AMTB) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please...
Recent Comments